Update on amyloid-associated intracerebral haemorrhage

European Neurological Review

Volumn 7, Issue 1, 2012, Pages 22-24

  Grysiewicz, Rebbeca ^a   Gorelick, Philip B ^b,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b Saint Mary's Health Care   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Cerebral amyloid angiopathy; Cerebral microbleeds; Intracerebral haemorrhage; Lobar haemorrhage

Indexed keywords

EID: 84865170374     PISSN: 17583837     EISSN: 17583845     Source Type: Journal    
DOI: 10.17925/ENR.2012.07.01.22     Document Type: Article

References (50)

1. Vinters HV, Cerebral amyloid angiopathy. A critical review, Stroke, 1987;18:311-24.
2. Gorelick PB, Cerebral microbleeds. Evidence of heightened risk associated with aspirin use, Arch Neurol, 2009;66:691-3.
3. Greenberg SM, Rapalino O, Frosch MP, Case 22-2010: An 87-year-old woman with dementia and a seizure, N Engl J Med, 2010;363:373-81.
4. Smith EE, Greenberg SM, B-amyloid, blood vessels, and brain function, Stroke, 2009;40:2601-6.
5. Zipfel GJ, Han H, Ford AL, Lee JM, Cerebral amyloid angiopathy. Progressive disruption of the neurovascular unit, Stroke, 2009;40(3 Suppl.):S16-9.
6. Iadecola C, Gorelick PB, Converging pathogenic mechanisms in vascular and neurodegenerative dementia, Stroke, 2003;34:335-7.
7. Iadecola C, Davisson RL, Hypertension and cerebrovascular dysfunction, Cell Metab, 2008;7:476-84.
8. Attems J, Jellinger K, Thal DR, Van Nostrand W, Review: Sporadic cerebral amyloid angiopathy, Neuropathol Appl Neurobiol, 2011;37:75-93.
9. Viswanathan A, Chabriat H, Cerebral microhemorrhage, Stroke, 2006;37:550-5.
10. Greenberg SM, Vernooij MW, Cordonnier C, et al., Microbleed Study Group. Cerebral microbleeds: a guide to detection and interpretation, Lancet Neurol, 2009;8(2):165-74.
11. Goos JDC, Henneman WJP, Sluimer JD, et al., Incidence of cerebral microbleeds. A longitudinal study in a memory clinic population, Neurology, 2010;74:1954-60.
12. Gorelick PB, Scuteri A, Black SE, et al., Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, 2011;42:2672-2713.
13. Viswanathan A, Greenberg SM, Cerebral amyloid angiopathy in the elderly, Ann Neurol, 2011;70:871-80.
14. Knudsen KA, Rosand J, Karluk D, Greenberg SM, Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria, Neurology, 2001;56:537-9.
15. Greenberg SM, Eng JA, Ning M, et al., Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage, Stroke, 2004;35:1415-20.
16. Rosand J, Muzikansky A, Kumar A, et al., Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy, Ann Neurol, 2005;58:459-62.
17. Greenberg SM, Nandigam K, Delgado P, et al., Microbleeds versus macrobleeds. Evidence for distinct entities, Stroke, 2009;40:2382-6.
18. Jellinger KA, Alzheimer disease and cerebrovascular pathology: an update, J Neural Transm, 2002;109:813-36.
19. Neuropathology Group, Medical Research Council Cognitive Function and Ageing Study, Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS), Lancet, 2001;357:169-75.
20. Greenberg SM, Cerebral amyloid angiopathy. In: Mohr JP, Choi D, Grotta JC, et al. (eds), Stroke: Pathophysiology, Diagnosis and Management, 4th edition, Philadelphia, PA: Churchill Livingstone, 2004;693-705.
21. Vernooij MW, van der Lugt A, Ikram MA, et al., Prevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study, Neurology, 2008;70:1208-14.
22. Poels MF, Ikram MA, van der Lugt A, et al., Incidence of cerebral microbleeds in the general population: The Rotterdam Scan Study, Stroke, 2011;42:656-61.
23. Smith EE, Nandigam KR, Chen YW, et al., MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage, Stroke, 2010;41:1933-8.
24. Altmann-Schneider I, Trompet S, de Craen A, et al., Cerebral microbleeds are predictive of mortality in the elderly, Stroke, 2011;42:638-44.
25. Greenberg SM, Vonsattel JP, Segal AZ, et al., Association of apolipoprotein E e{open}2 and vasculopathy in cerebral amyloid angiopathy, Neurology, 1998;50:961-5.
26. Biffi A, Anderson CD, Jagiella JM, et al., APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study, Lancet Neurol, 2011;10:702-9.
27. Palsdottir A, Snorradottir AO, Thorsteinsson L, Hereditary cystatin C amyloid angiopathy: genetic, clinical, and pathological aspects, Brain Pathol, 2006;16:55-9.
28. Resvesz T, Holton JL, Lashley T, et al., Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies, Acta Neuropathol, 2009;118:115-30.
29. Biffi A, Greenberg SM, Cerebral amyloid angiopathy: A systemic review, J Clin Neurol, 2011;7:1-9.
30. Broderick J, Connolly S, Feldmann E, et al., Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group, Circulation, 2007;116:e391-413.
31. Smith EE, Gurol ME, Eng JA, et al., White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage, Neurology, 2004;63:1606-12.
32. Pfeifer LA, White LR, Ross GW, et al., Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study, Neurology, 2002;58:1629-34.
33. Arvanitakis Z, Leurgans SE, Wang Z, et al., Cerebral amyloid angiopathy pathology and cognitive domains in older persons, Ann Neurol, 2011;69:320-7.
34. Soontornniyomkij V, Lynch MD, Mermash S, et al., Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy, Brain Pathol, 2010;20:459-67.
35. Kimberly WT, Gilson A, Rost NS, et al., Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy, Neurology, 2009;72:1230-5.
36. Beitzke M, Gattringer T, Enzinger C, et al., Clinical presentation, etiology and long-term prognosis in patients with nontraumatic convexal subarachnoid hemorrhage, Stroke, 2011;42:3055-60.
37. Kinnecom C, Lev MH, Wendell L, et al., Course of cerebral amyloid angiopathy-related inflammation, Neurology, 2007;68:1411-6.
38. Olichney JM, Hansen LA, Hofstetter CR, et al., Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension, Arch Neurol, 1995;52:702-8.
39. Vonsattel JP, Myers RH, Hedley-Whyte ET, et al., Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study, Ann Neurol, 1991;30:637-49.
40. Linn J, Halpin A, Demaerel P, et al., Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy, Neurology, 2010;74:1346-50.
41. Johnson KA, Gregas M, Becker JA, et al., Imaging of amyloid burden and distribution in cerebral amyloid angiopathy, Ann Neurol, 2007;62:229-34.
42. Ly JV, Rowe CC, Villemagne VL, et al., Cerebral 4-amyloid detected by Pittsburgh compound B positron emission topography predisposes to recombinant tissue plasminogen activator-related hemorrhage, Ann Neurol, 2010;68:959-62.
43. Sunderland T, Linker G, Mirza N, et al., Decreased betaamyloid1-42 and increased tau levels in cerebrospinal fluid in patients with Alzheimer disease, JAMA, 2003;298:2094-103.
44. Verbeek MM, Kremer BP, Rikkert MO, et al., Cerebrospinal fluid amyloid beta (40) is decreased in cerebral amyloid angiopathy, Ann Neurol, 2009;66:245-9.
45. Pantoni L, Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges, Lancet Neurol, 2010;9:689-701.
46. Salat DH, Smith EE, Tuch DS, et al., White matter alterations in cerebral amyloid angiopathy measured by diffusion tensor imaging, Stroke, 2006;37:1759-64.
47. Biffi A, Halpin A, Towfighi A, et al., Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy, Neurology, 2010;75:693-8.
48. Arima H, Tzourio C, Anderson C, et al., Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial, Stroke, 2010;41:394-6.
49. Schroeter S, Khan K, Barbour R, et al., Immunotherapy reduces vascular amyloid-beta in PDAPP mice, J Neurosci, 2008;28:6787-93.
50. Kloppenborg RP, Richard E, Sprengers ME, et al., Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment, J Neuroinflammation, 2010;7:18.